Related references
Note: Only part of the references are listed.Resurgence of pneumococcal meningitis in Europe and Northern America
D. L. H. Koelman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Making sense of differences in pneumococcal serotype replacement
Joseph A. Lewnard et al.
LANCET INFECTIOUS DISEASES (2019)
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study
Stephanie W. Lo et al.
LANCET INFECTIOUS DISEASES (2019)
Novel insights into pneumococcal lineages in the vaccine era
Emmanuelle Varon et al.
LANCET INFECTIOUS DISEASES (2019)
Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe
Corinne Levy et al.
JOURNAL OF PEDIATRICS (2019)
Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies
Shalom Ben-Shimol et al.
VACCINE (2018)
Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
Patricia Izurieta et al.
EXPERT REVIEW OF VACCINES (2018)
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis
Evelyn Balsells et al.
JOURNAL OF INFECTION (2018)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Invasive pneumococcal disease in children under 16 years of age: Incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in Germany
Raphael Weinberger et al.
VACCINE (2018)
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15
Brian Wahl et al.
LANCET GLOBAL HEALTH (2018)
Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey
Naim Ouldali et al.
LANCET INFECTIOUS DISEASES (2018)
Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016
Shalom Ben-Shimol et al.
EUROSURVEILLANCE (2018)
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci
Taj Azarian et al.
PLOS PATHOGENS (2018)
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7-and 13-Valent Vaccines, Israel
Assaf Rokney et al.
EMERGING INFECTIOUS DISEASES (2018)
Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries
Robert Cohen et al.
EXPERT REVIEW OF VACCINES (2017)
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
Christopher Troeger et al.
LANCET INFECTIOUS DISEASES (2017)
Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006
A Lepoutre et al.
Eurosurveillance (2017)
Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations
Racquel Jandoc et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children
Emmanuelle Varon et al.
VACCINE (2015)
Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012
A. Lepoutre et al.
VACCINE (2015)
Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis
Evangelos Kontopantelis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis
Evangelos Kontopantelis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
F. Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2014)
Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction
S. Georges et al.
EPIDEMIOLOGY AND INFECTION (2013)
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
Daniel R. Feikin et al.
PLOS MEDICINE (2013)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller et al.
LANCET INFECTIOUS DISEASES (2011)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media
Robert Cohen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Segmented regression analysis of interrupted time series studies in medication use research
AK Wagner et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2002)
Share Paper
